Cargando…

Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial

BACKGROUND: Bronchopulmonary dysplasia (BPD), an inflammatory-mediated chronic lung disease, is common in extremely preterm infants born before 28 weeks’ gestation and is associated with an increased risk of adverse neurodevelopmental and respiratory outcomes in childhood. Effective and safe prophyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manley, Brett J., Kamlin, C. Omar F., Donath, Susan, Huang, Li, Birch, Pita, Cheong, Jeanie L. Y., Dargaville, Peter A., Dawson, Jennifer A., Doyle, Lex W., Jacobs, Susan E., Wilson, Rodney, Davis, Peter G., McKinlay, Christopher J. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169381/ https://www.ncbi.nlm.nih.gov/pubmed/37161488 http://dx.doi.org/10.1186/s13063-023-07257-5

Ejemplares similares

Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial
por: Francis, Kate L, et al.
Publicado: (2023)

The efficacy of intratracheal administration of surfactant and budesonide combination in the prevention of bronchopulmonary dysplasia
por: Gharehbaghi, Manizheh Mostafa, et al.
Publicado: (2021)

A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia
por: Gharehbaghi, Manizheh M., et al.
Publicado: (2021)

Use of budesonide associated with a pulmonary surfactant to prevent bronchopulmonary dysplasia in premature newborns – A systematic review
por: Moraes, Lucas Hirano Arruda, et al.
Publicado: (2022)

Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)
por: McEvoy, Cindy T., et al.
Publicado: (2020)

The SHINE trial (a multicentre, randomised trial of stabilisation with nasal high flow during neonatal endotracheal intubation): statistical analysis plan
por: Hodgson, Kate, et al.
Publicado: (2021)

The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation
por: Dargaville, Peter A, et al.
Publicado: (2014)

Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS
por: Deliloglu, Burak, et al.
Publicado: (2020)

Association between Postnatal Dexamethasone for Treatment of Bronchopulmonary Dysplasia and Brain Volumes at Adolescence in Infants Born Very Preterm
por: Cheong, Jeanie L.Y., et al.
Publicado: (2014)

A multicentre, randomised trial of stabilisation with nasal high flow during neonatal endotracheal intubation (the SHINE trial): a study protocol
por: Hodgson, Kate A, et al.
Publicado: (2020)

Expiratory airflow at 7–8 years of age in children born extremely low birthweight from 14 years before to 14 years after the introduction of exogenous surfactant
por: Doyle, Lex W., et al.
Publicado: (2023)

Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide In Vivo
por: Baer, Brandon, et al.
Publicado: (2020)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

Intra‐tracheal surfactant/budesonide versus surfactant alone: Comparison of two consecutive cohorts of extremely preterm infants
por: Moschino, Laura, et al.
Publicado: (2021)

Surfactant-Assisted Distal Pulmonary Distribution of Budesonide Revealed by Mass Spectrometry Imaging
por: Zecchi, Riccardo, et al.
Publicado: (2021)

A good career start can open doors: the plusses and minuses of an international graduate student program—a student’s perspective
por: Malik, Anchal
Publicado: (2020)

A Multiprofessional and Intersectoral Working Model to Detect and Support Preschool Children With Neurodevelopmental Difficulties (PLUSS Model): Protocol for an Evaluation Study
por: Gustafsson, Berit M, et al.
Publicado: (2022)

Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm
por: Sullivan, Thomas R., et al.
Publicado: (2023)

Budesonide/Formoterol Enhances the Expression of Pro Surfactant Protein-B in Lungs of COPD Patients
por: Um, Soo Jung, et al.
Publicado: (2013)

Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration
por: Chen, Chung-Ming, et al.
Publicado: (2019)

Blood metabolomics in infants enrolled in a dose escalation pilot trial of budesonide in surfactant
por: Ballard, Philip L., et al.
Publicado: (2021)

Association of Fetal Growth Restriction With Neurocognitive Function After Repeated Antenatal Betamethasone Treatment vs Placebo: Secondary Analysis of the ACTORDS Randomized Clinical Trial
por: Cartwright, Robert D., et al.
Publicado: (2019)

Intratracheal Keratinocyte Growth Factor Enhances Surfactant Protein B Expression in Mechanically Ventilated Preterm Pigs
por: Krishnan, Ramesh, et al.
Publicado: (2021)

Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome
por: Goudarzi, Razieh Moazami, et al.
Publicado: (2023)

A Note on the Mortality from Pernicious Anæmia in Scotland, with Special Reference to the Influence of Liver Treatment
por: McKinlay, Peter L.
Publicado: (1930)

Certain Types of Alimentary Neurosis
por: McKinlay, Peter C.
Publicado: (1937)

Intratracheal Injections
Publicado: (1891)

Intratracheal Insufflation
por: Ricketts, Benjamin Merrill
Publicado: (1916)

Intratracheal Medication
por: Forsyth, Edgar A.
Publicado: (1902)

Multi-professional and multi-agency model PLUSS to facilitate early detection and support of pre-school children with neurodevelopmental difficulties – a model description
por: Gustafsson, Berit M., et al.
Publicado: (2022)

Effectiveness of intratracheal salbutamol in addition to surfactant on the clinical course of newborns with respiratory distress syndrome: a clinical trial
por: Dehdashtian, Masoud, et al.
Publicado: (2016)

Probiotics, prematurity and neurodevelopment: follow-up of a randomised trial
por: Jacobs, Susan E, et al.
Publicado: (2017)

Intratracheal instillation versus intratracheal inhalation: influence of cytokines on inflammatory response.
por: Osier, M, et al.
Publicado: (1997)

Comparative evaluation of the health utilities index mark 3 and the short form 6D: evidence from an individual participant data meta-analysis of very preterm and very low birthweight adults
por: Bolbocean, Corneliu, et al.
Publicado: (2023)

Genetic Variants of Surfactant Proteins A, B, C, and D in Bronchopulmonary Dysplasia
por: Pavlovic, J., et al.
Publicado: (2006)

Dose of budesonide with surfactant affects lung and systemic inflammation after normal and injurious ventilation in preterm lambs
por: Hillman, Noah H, et al.
Publicado: (2020)

The Intratracheal Insufflation of Ether
por: Thomson, H. Torrance, et al.
Publicado: (1914)

Exuberant Intratracheal Granuloma
por: Stuart, Emelia, et al.
Publicado: (2021)

Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome
por: Mohammadizadeh, Majid, et al.
Publicado: (2015)

Budesonide with surfactant decreases systemic responses in mechanically ventilated preterm lambs exposed to fetal intra-amniotic lipopolysaccharide
por: Hillman, Noah H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1q7n2kp768j5s4e3rgnjdr52s6